When pancreatic cancer is suspected or diagnosed, the next useful step is to clarify the cancer type, its extent, and which findings determine treatment. Collecting the reports and asking focused questions can make a complex specialist consultation easier to follow.
Confirm the type and the immediate need
Most pancreatic cancers arise in the exocrine cells involved in digestion, often as ductal adenocarcinoma. Pancreatic neuroendocrine tumors form a different group, with their own biology and treatment pathways. Ask for the full pathology name before comparing statistics, medicines or another person’s experience.
NCI’s pancreatic neuroendocrine tumor guide addresses that distinct diagnosis. This page primarily orients readers to pancreatic adenocarcinoma. If the report is uncertain or tissue testing is pending, ask which decisions can be made now and which should wait for confirmation.
NCI’s symptom guide describes concerns such as jaundice, abdominal or back pain, weight loss and appetite changes. These symptoms can have other causes, but they need evaluation. Contact a clinician promptly for new jaundice, and seek urgent care for severe illness, fever with jaundice or inability to keep fluids down.
Understand what each test contributes
NCI’s diagnosis guide explains imaging, tissue sampling and laboratory assessment. CT or MRI helps map the pancreas, nearby structures and possible spread. Endoscopic ultrasound can provide a closer view and help obtain tissue. The team chooses the procedure according to the clinical question and safety considerations.
A biopsy lets a pathologist identify cells or tissue. Ask whether the sample is sufficient for diagnosis and any planned molecular testing, and whether specialist pathology review would help. Bring access to the actual imaging as well as written reports when seeking another opinion.
Blood tests can assess liver function and other aspects of health. A marker such as CA 19-9 is interpreted with imaging, symptoms and other findings; it is not a stand-alone answer to whether a person has cancer. MedlinePlus explains the test’s uses and limits. Ask what question the marker is being used to track and what else could affect its interpretation.
Separate stage from surgical assessment
On a small screen, scroll the table sideways. Keyboard users can focus the table region and use the arrow keys.
| Term | What the team is assessing | Question for the visit |
|---|---|---|
| Resectable | Whether complete surgical removal appears technically possible. | Would surgery or another treatment come first, and why? |
| Borderline resectable | Whether involvement near vessels makes complete removal uncertain. | What treatment and reassessment could clarify the surgical option? |
| Locally advanced | Cancer remains in the region but cannot currently be completely removed. | What is the treatment goal and how will response be assessed? |
| Metastatic | Cancer has spread to distant sites. | Which systemic and supportive treatments fit my health and priorities? |
NCI’s staging explanation distinguishes these surgical categories from the stage number. A surgeon’s assessment also considers the person’s fitness for a major operation. Ask whether pancreatic surgeons, medical oncologists, radiologists and other relevant specialists have reviewed the case together.
These categories can guide the sequence of treatment, but a table cannot assign one from a scan description. Ask the team to show which finding drives its assessment, whether further testing is needed, and when it would reconsider the plan.
The guide to local, regional and distant spread provides background for reading the staging language in your reports.
Discuss inherited and tumor testing separately
Inherited, or germline, testing looks for variants that may affect both care and relatives’ risk. Tumor testing looks for molecular features of the cancer that may guide treatment or trial options. NCI’s genetic-testing fact sheet explains why counseling and interpretation matter.
Ask about both tests early enough for the results to inform decisions. NCI’s biomarker-testing guide explains that a reported alteration must be connected to a treatment supported for the relevant cancer and setting. Some results have no established treatment implication; a “negative” report should be interpreted in the context of what the test actually examined.
Record whether a result is inherited or tumor-only, the laboratory and report date, and whether an additional consultation or family discussion is recommended. The specialist can explain consent, possible incidental findings and the next steps for relatives when relevant.
Use the guide to positive, negative and uncertain inherited-test results to prepare questions about what your report means for you and relatives.
Ask about goals, sequence and tradeoffs
NCI’s pancreatic treatment overview describes chemotherapy, surgery, radiation in selected situations, and targeted or immune-based treatment for suitable disease features. The choice depends on cancer extent, test results, health, prior treatment and personal priorities. Drug options change, so use the current source and the oncology team to confirm the proposed regimen.
Surgery for pancreatic cancer is complex; the operation depends on the tumor’s location and extent. Medicines may be given before or after surgery, or as the main cancer treatment when removal is not appropriate. Ask what benefit the team expects, which harms are most relevant to you, and what finding would lead it to continue or change course.
Ask about clinical trials before beginning a new treatment, because prior therapy can affect eligibility. Request an explanation of the trial’s purpose, comparison treatment, extra visits and costs. Published survival figures describe study groups; your team can explain which information is relevant to your own outlook.
Build symptom care into the plan
NCI explains palliative care as help with symptoms, distress and quality of life alongside cancer treatment. Ask early about pain, nausea, fatigue, eating, sleep and emotional support. Supportive care is useful throughout the illness.
Pancreatic disease or surgery can affect digestion and blood sugar. Report weight loss, difficulties eating or stool changes and ask whether dietitian input, pancreatic enzymes or diabetes care is needed. If a bile duct or the digestive passage is blocked, the team may discuss a stent or another procedure to relieve it. Use individualized instructions for medicines, nutrition and aftercare.
Download the pancreatic consultation notes for diagnosis, pending results, treatment goals and practical support. Before leaving, confirm the next appointment, who will explain outstanding results, and when to call sooner.
Updated October 9, 2026. General education for conversations with qualified health professionals; individual care depends on your history, results and local guidance.
Explore the Cancer guides and topic directory.